The synthesis and structure-activity relationships of a novel series of substituted quercetins that activates peroxisome proliferator-activated receptor gamma (PPARgamma) are reported. The PPARgamma agonistic activity of the most potent compound in this series is comparable to that of the thiazolidinedione-based antidiabetic drugs currently in clinical use.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/BF02977705 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!